Article
p95HER2 and Breast Cancer
23 Feb 2011
Abstract excerpt
A subtype of HER2-positive tumors with distinct biological and clinical features expresses a series of carboxy-terminal fragments collectively known as p95HER2. One of these fragments, named 100- to 115-kDa p95HER2 or 611-CTF, is hyperactive because of its ability to form homodimers maintained by intermolecular disulfide bonds. Despite lacking the majority of the extracellular domain, this HER2 fragment drives...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
